Novo Nordisk A/S in 1 story
The narratives NVO currently appears in, with its side and exposure in each.
Bull side
1 story- GLP-1 Eats Everything
NVO in “GLP-1 Eats Everything”
FadingExposure: not rated yetAppetite suppression as a macro variable.
Second scaled incretin platform with global reach.
Bear side
0 storiesNo bear-side stories for NVO yet.